Your browser doesn't support javascript.
loading
Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
Jimenez, Anthony D; Gopaul, Margaret; Asbell, Hannah; Aydemir, Seyhmus; Basha, Maysaa M; Batra, Ayush; Damien, Charlotte; Day, Gregory S; Eka, Onome; Eschbach, Krista; Fatima, Safoora; Fields, Madeline C; Foreman, Brandon; Gerard, Elizabeth E; Gofton, Teneille E; Haider, Hiba A; Hantus, Stephen T; Hocker, Sara; Jongeling, Amy; Kalkach Aparicio, Mariel; Kandula, Padmaja; Kang, Peter; Kazazian, Karnig; Kellogg, Marissa A; Kim, Minjee; Lee, Jong Woo; Marcuse, Lara V; McGraw, Christopher M; Mohamed, Wazim; Orozco, Janet; Pimentel, Cederic; Punia, Vineet; Ramirez, Alexandra M; Steriade, Claude; Struck, Aaron F; Taraschenko, Olga; Treister, Andrew K; Yoo, Ji Yeoun; Zafar, Sahar; Zhou, Daniel J; Zutshi, Deepti; Gaspard, Nicolas; Hirsch, Lawrence J; Hanin, Aurelie.
Affiliation
  • Jimenez AD; Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Gopaul M; Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Asbell H; Section of Neurology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Aydemir S; Department of Neurology, Weill Cornell Medicine, New York, New York, USA.
  • Basha MM; Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Batra A; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Damien C; Department of Neurology, Hôpital Universitaire de Bruxelles-Hôpital Erasme, Brussels, Belgium.
  • Day GS; Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Eka O; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Eschbach K; Section of Neurology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Fatima S; Department of Neurology, University of Wisconsin, Madison, Wisconsin, USA.
  • Fields MC; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Foreman B; Division of Neurocritical Care, Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Gerard EE; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Gofton TE; University Hospital London Health Sciences Center, London, Ontario, Canada.
  • Haider HA; Epilepsy Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Hantus ST; Department of Neurology, University of Chicago, Chicago, Illinois, USA.
  • Hocker S; Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Jongeling A; Mayo Clinic, Minnesota, Rochester, Minnesota, USA.
  • Kalkach Aparicio M; NYU Comprehensive Epilepsy Center, NYU Langone Medical Center, New York, New York, USA.
  • Kandula P; Department of Neurology, University of Wisconsin, Madison, Wisconsin, USA.
  • Kang P; Department of Neurology, Weill Cornell Medicine, New York, New York, USA.
  • Kazazian K; Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Kellogg MA; University Hospital London Health Sciences Center, London, Ontario, Canada.
  • Kim M; Oregon Health & Science University, Portland, Oregon, USA.
  • Lee JW; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Marcuse LV; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • McGraw CM; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Mohamed W; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Orozco J; Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Pimentel C; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Punia V; Neurocritical Care, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Ramirez AM; Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Steriade C; Division of Neurocritical Care, Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Struck AF; NYU Comprehensive Epilepsy Center, NYU Langone Medical Center, New York, New York, USA.
  • Taraschenko O; Department of Neurology, University of Wisconsin, Madison, Wisconsin, USA.
  • Treister AK; Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Yoo JY; Oregon Health & Science University, Portland, Oregon, USA.
  • Zafar S; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Zhou DJ; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Zutshi D; Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Gaspard N; Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Hirsch LJ; Department of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Hanin A; Department of Neurology, Hôpital Universitaire de Bruxelles-Hôpital Erasme, Brussels, Belgium.
Epilepsia ; 65(6): e87-e96, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38625055
ABSTRACT
Febrile infection-related epilepsy syndrome (FIRES) is a subset of new onset refractory status epilepticus (NORSE) that involves a febrile infection prior to the onset of the refractory status epilepticus. It is unclear whether FIRES and non-FIRES NORSE are distinct conditions. Here, we compare 34 patients with FIRES to 30 patients with non-FIRES NORSE for demographics, clinical features, neuroimaging, and outcomes. Because patients with FIRES were younger than patients with non-FIRES NORSE (median = 28 vs. 48 years old, p = .048) and more likely cryptogenic (odds ratio = 6.89), we next ran a regression analysis using age or etiology as a covariate. Respiratory and gastrointestinal prodromes occurred more frequently in FIRES patients, but no difference was found for non-infection-related prodromes. Status epilepticus subtype, cerebrospinal fluid (CSF) and magnetic resonance imaging findings, and outcomes were similar. However, FIRES cases were more frequently cryptogenic; had higher CSF interleukin 6, CSF macrophage inflammatory protein-1 alpha (MIP-1a), and serum chemokine ligand 2 (CCL2) levels; and received more antiseizure medications and immunotherapy. After controlling for age or etiology, no differences were observed in presenting symptoms and signs or inflammatory biomarkers, suggesting that FIRES and non-FIRES NORSE are very similar conditions.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Fever Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Epilepsia Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Status Epilepticus / Fever Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Epilepsia Year: 2024 Document type: Article Affiliation country: